- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07495436
Video- versus direkte Laryngoskopie zur Trachealintubation in der Kinderchirurgie (VIDEOKIDS)
Videolaryngoskopie versus direkte Laryngoskopie zur trachealen Intubation in der Kinderchirurgie: Die VIDEOKIDS pragmatische multizentrische randomisierte Studie.
Tracheal intubation in paediatric patients is a high-risk procedure in which failure to achieve successful intubation on the first attempt is associated with an increased risk of complications, including hypoxaemia and airway trauma. Videolaryngoscopes have been increasingly adopted in clinical practice because they improve glottic visualisation; however, evidence of their benefit in paediatric patients remains inconsistent.
The VIDEOKIDS trial is a large, pragmatic, international, multicentre, randomised controlled trial designed to compare videolaryngoscopy with direct laryngoscopy as the initial technique for tracheal intubation in paediatric patients undergoing surgery under general anaesthesia. The primary objective is to determine whether videolaryngoscopy increases the rate of successful intubation on the first attempt compared with direct laryngoscopy.
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
The purpose of this prospective, international, multicentre, randomised controlled trial is to compare videolaryngoscopy with direct laryngoscopy as the initial technique for tracheal intubation in paediatric patients undergoing elective surgery under general anaesthesia. We hypothesise that videolaryngoscopy will increase the frequency of successful intubation on the first attempt compared with direct laryngoscopy.
Eligible patients aged 0 to 16 years requiring orotracheal intubation will be randomly assigned in a 1:1 ratio to videolaryngoscopy or direct laryngoscopy for the first intubation attempt. The specific device and blade type, as well as all aspects of peri-intubation management, including patient positioning, preoxygenation, and pharmacological agents, will be determined by the attending anaesthesiologist according to local practice.
The primary outcome is successful tracheal intubation on the first attempt. Secondary outcomes include time to intubation, number of intubation attempts, glottic visualisation, need for adjunct airway devices, and intubation-related complications.
The primary analysis will follow the intention-to-treat principle. A mixed-effects logistic regression model will be used to account for centre-level variability and prespecified clinically relevant covariates.
Current evidence in paediatric populations remains inconclusive, with recent meta-analyses showing no clear improvement in first-attempt success despite better glottic visualisation with videolaryngoscopy.
The trial is expected to enrol approximately 5,600 patients across 15 to 25 hospitals in multiple countries, including Spain and Latin America. Recruitment is planned to begin in May 2026.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Manuel Taboada Muñiz, Ph.D.
- Telefonnummer: +34678195618
- E-Mail: manutabo@yahoo.es
Studienorte
-
-
A CORUÑA
-
Santiago de Compostela, A CORUÑA, Spanien, 15706
- Rekrutierung
- Hospital Clínico Universitario de Santiago de Compostela
-
Kontakt:
- Manuel Taboada Muñiz, Ph.D.
- Telefonnummer: 0034 981950674
- E-Mail: manutabo@yahoo.es
-
Kontakt:
- Jorge Fernández, M.D.
- Telefonnummer: 0034 678195618
- E-Mail: manuel.taboada.muniz@sergas.es
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Paediatric patients (age 0-16 years),
- Undergoing elective or scheduled surgery under general anaesthesia requiring orotracheal intubation,
- Planned tracheal intubation using either videolaryngoscopy or direct laryngoscopy as the initial technique,
- Informed or general consent given, according to the relevant ethics committee statement,.
Exclusion Criteria:
- Known upper airway anatomical abnormalities or clinical conditions requiring a specific intubation technique (e.g., fibreoptic intubation),
- Requirement for emergent tracheal intubation that does not allow adequate randomisation,
- Refusal of parents or legal guardians to participate in the study.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Videolaryngoscope group
For patients assigned to the videolaryngoscope Group, the operator will use a video laryngoscope on the first laryngoscopy attempt. |
For patients assigned to the videolaryngoscope Group, the operator will use a video laryngoscope on the first laryngoscopy attempt. |
|
Aktiver Komparator: Direct laryngoscope group
For patients assigned to the laryngoscope Group, the operator will use a Macintosh laryngoscope on the first laryngoscopy attempt. |
For patients assigned to the laryngoscope Group, the operator will use a Macintosh laryngoscope on the first laryngoscopy attempt. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Number of intubations with successful tracheal intubation on the first attempt
Zeitfenster: Duration of procedure of procedure (minutes)
|
The primary outcome is successful tracheal intubation on the first attempt, defined as placement of an endotracheal tube in the trachea following a single insertion of the laryngoscope blade into the mouth, without its removal. |
Duration of procedure of procedure (minutes)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Successful intubation
Zeitfenster: Duration of procedure (minutes)
|
Successful placement of a tube in the trachea |
Duration of procedure (minutes)
|
|
Incidence of "easy intubation"
Zeitfenster: Duration of procedure (minutes)
|
Easy intubation is defined as a patient with modified Cormack-Lehane I-IIa glottic view and intubation on the first attempt. |
Duration of procedure (minutes)
|
|
Number of laryngoscopy attempts
Zeitfenster: Duration of procedure (minutes)
|
Number of laryngoscopy attempts |
Duration of procedure (minutes)
|
|
Number of attempts to cannulate the trachea with a bougie or an endotracheal tube
Zeitfenster: Duration of procedure (minutes)
|
Number of attempts to cannulate the trachea with a bougie or an endotracheal tube |
Duration of procedure (minutes)
|
|
Duration of tracheal intubation
Zeitfenster: Duration of procedure (minutes)
|
The interval (in seconds) between the first insertion of a laryngoscope blade into the mouth and the final placement of an endotracheal tube in the trachea. |
Duration of procedure (minutes)
|
|
Reason for failure to intubate on the first attempt
Zeitfenster: Duration of procedure (minutes)
|
Reason for failure among those who did not meet the primary outcome (successful intubation on the first attempt):
|
Duration of procedure (minutes)
|
|
Operator-assessed difficulty of intubation
Zeitfenster: Duration of procedure (minutes)
|
Operator-assessed difficulty of intubation
|
Duration of procedure (minutes)
|
|
Glottic view assessed using the modified Cormack-Lehane classification
Zeitfenster: Duration of procedure (minutes)
|
Modified Cormack-Lehane grade of glottic view: I: full view of the glottis, IIa: partial view of the glottis, IIb: arytenoid or posterior part of the vocal cords just visible, III: only epiglottis visible, IV: neither glottis nor epiglottis visible Cormack-Lehane grade of glottic view |
Duration of procedure (minutes)
|
|
Glottic view assessed using the percentage of glottic opening (POGO score).
Zeitfenster: Duration of procedure (minutes)
|
The Percentage of Glottic Opening (POGO) score is defined as the percentage (0% to 100%) of the glottic opening visualised during laryngoscopy, from the anterior commissure to the interarytenoid notch. A score of 0% indicates that no glottic structures are visible, whereas 100% indicates full visualisation of the glottis. |
Duration of procedure (minutes)
|
|
Need for additional airway equipment
Zeitfenster: Duration of procedure (minutes)
|
Airway equipment: bougie, stylet, other videolaryngoscope, others. |
Duration of procedure (minutes)
|
|
Need to change the device for intubation
Zeitfenster: Duration of procedure (minutes)
|
Need to replace by another device, a different angled blade, requirement for a fiberoptic bronchoscope...). |
Duration of procedure (minutes)
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Complications of tracheal intubation
Zeitfenster: From induction to 15 minutes following tracheal intubation
|
|
From induction to 15 minutes following tracheal intubation
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Manuel Taboada Muñiz, University Clinical Hospital of Santiago de Compostela
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- VIDEOKIDS Trial
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Individual participant data will not be routinely shared due to regulatory and data protection restrictions across participating countries. Data access may be considered on a case-by-case basis, subject to applicable regulations and approval by the study investigators.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .